MRK

Teva Pharmaceuticals (TEVA): The Best Long-Term Play in Pharma

Generic drugmaker Teva Pharmaceuticals has a drab but stable long-term business that makes TEVA stock a clear buy in the pharma industry. More 

4 Big Pharma Stocks to Own After Q2 Earnings

Big Pharma has a lot to be proud of following some key second-quarter filings and revised full-year outlooks. Four stocks in particular look buy-worthy. More 

Report: New Ebola Vaccine Is ‘Highly Effective’

A new Ebola vaccine provided by Merck is being called 'highly effective' following a small study in Guinea, West Africa. More 

Hottest Healthcare Stocks Now – EXAM GSK PFE WX

Healthcare stocks rose 0.3% on Wall Street on Wednesday morning. More 

Hottest Healthcare Stocks Now – ELGX RGEN MASI AMED

Healthcare stocks finished up 0.2% on Wall Street today. More 

3 Big Pharmaceutical Stocks Flashing Warning Signs

Pharmaceutical stocks have been tearing up the markets over the years but recent technical indicators provide a cautionary tone. More 

Allergan (AGN) Buys Exclusive Rights to Merck (MRK) Migraine Drugs

Allergan has bought the exclusive rights to two of Merck's migraine drugs for $250 million and may also pay royalties for their use. More